DBV Technologies S.A. News
DBV Technologies Spikes on Positive FDA Communication
DBV says it received positive feedback concerning its peanut allergy treatment.
Endurance International, Farfetch: 5 Top Stock Gainers for Monday
Endurance International, DBV Technologies, Farfetch, Lumber Liquidators and Insperity are five top stock gainers for Monday
DBV Soars on European Validation of Peanut Allergy Patch Application
DBV said it expects to receive the first set of questions from the EMA regarding marketing approval about 120 days post-validation.
DBVT Rises On New Data For Peanut Allergy Drug; Bitcoin Rockets Past $8,000 -- ICYMI
Here's what you need to know now for Monday, Nov. 20.
The Hartford, Aetna Ink Tie-Up; All Eyes on Peanut Allergies -- ICYMI
Here's what you need to know now for Monday, Oct. 23.
Biotech Movers: Synergy Pharmaceuticals Explodes 15%, and Bluebird Bio May Be Next
Synergy Pharmaceuticals, Bluebird Bio and DBV Technologies were among the biotech stock movers in early trading on Friday.
7 stocks spiking on big volume--here's how to trade them
These stocks rising on unusual volume are within range of triggering big breakout trades.
A New Take on the Big Mac (May Be) Headed to U.S. McDonald's Menus
This is very different than the Big Mac you know and love.
We're Enduring 'Housing Recession,' Homebuilders' Economist Says
The builder confidence index breached the break-even measure of 50 in August for the first time since May 2020.